Results 161 to 170 of about 91,055 (253)

Multiple Coronary Artery Fistulas and 3-Vessel Disease in an Elderly Patient With Unstable Angina. [PDF]

open access: yesJACC Case Rep
Rodríguez EA   +5 more
europepmc   +1 more source

A cost‐effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 5748-5760, October 2025.
Abstract Aims Effective weight management pharmacotherapies are a new alternative to bariatric surgery or health behaviour intervention (HBI) alone. Comparative cost‐effectiveness evaluations can guide decision‐making. We aimed to evaluate the cost‐effectiveness of sleeve gastrectomy (SG), Roux‐en‐Y gastric bypass (RYGB), semaglutide, tirzepatide, and ...
Nisha Gupta   +5 more
wiley   +1 more source

Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study (TWINKLE)

open access: yesJournal of Diabetes Investigation, Volume 16, Issue 10, Page 1808-1819, October 2025.
This study confirmed the long‐term safety and efficacy of an adjusted‐dose regimen of imeglimin in Japanese participants with type 2 diabetes and grade (G) 3b–5 chronic kidney disease (CKD). Adverse events occurred in 41 participants (68.3%), with no increase in the incidence, type, and severity of AEs between CKD cohorts.
Tetsuya Babazono   +10 more
wiley   +1 more source

Intersectionality of inequalities in revascularization and outcomes for acute coronary syndrome in England: nationwide linked cohort study. [PDF]

open access: yesEur Heart J Qual Care Clin Outcomes
Roman M   +10 more
europepmc   +1 more source

From Bench to Clinic: Advances in Anti‐Inflammatory Therapies for Atherosclerotic Coronary Artery Disease

open access: yesThe FASEB Journal, Volume 39, Issue 18, 30 September 2025.
The changing face of AS. This diagram illustrates the research landscape of ASCAD. It highlights a shift in understanding from viewing it as a lipid storage disease to recognizing it as a chronic inflammatory disease. Additionally, emerging therapies like colchicine, methotrexate, IL‐1 blockade, IL‐6 blockade, darapladib, and low‐dose IL‐2 are being ...
Kan Wang   +4 more
wiley   +1 more source

The causal effects of remnant cholesterol on increased risk of cardiovascular diseases in East Asians. [PDF]

open access: yesBMC Med
Lin C   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy